Doximity (DOCS) CAO Siddharth Sitaram Sells $80K of Stock

Doximity, Inc. Chief Accounting Officer Siddharth Sitaram sold 2,613 shares of the company's stock on October 14, 2026. According to a Form 4 filed with the Securities and Exchange Commission, the transaction was executed at a price of $30.68 per share, totaling $80,166.84. This pre-arranged sale took place as shares traded close to the company's recent price levels.

Inside Siddharth Sitaram's Doximity Trade

The Chief Accounting Officer executed the planned sale under a Rule 10b5-1 trading plan. The transaction involved 2,613 shares at $30.68 apiece. On the day of the trade, Doximity closed at $29.92 on the New York Stock Exchange.

Other Institutional Activity in Doximity

Large financial institutions have seen shifting positions in Doximity over recent reporting periods. Shaw D.E. & Co., Inc. grew its holdings by 3,021,003 shares, ending with 5,922,188 shares worth about $183,410,158. Two Sigma Investments, LP grew its holdings by 3,277,149 shares, ending with 4,647,309 shares worth about $143,927,156. Deutsche Bank AG reduced its holdings by 29,228 shares, ending with 2,893,534 shares worth about $89,612,745. Fundsmith trimmed its holdings by 958,216 shares, ending with 691,786 shares worth about $13,863,392.

Doximity, Inc. Stock Down 2.4%

The stock recently traded around $30.73 as of October 16, 2026, putting it up about 2.7% since the insider sale. Shares trade above both their 50-day and 200-day moving averages.

Recent Earnings

The healthcare technology firm generated trailing-twelve-month revenue of $655,568,000 with a net margin of 25.5%. Its next financial results arrive on November 5, 2026.

Insider Buying and Selling at Doximity, Inc.

Insiders have recorded multiple transactions leading up to this filing. Director Kira Scherer Wampler sold 2,000 shares on August 25, 2026, at $24.95 per share. Wampler sold another 2,000 shares on September 1, 2026, at $26.33 per share, and an additional 2,000 shares on October 1, 2026, at $28.91 per share. Siddharth Sitaram previously sold 2,077 shares on September 15, 2026, at $26.02 per share.

Analysts Set New Price Targets

Wall Street firms maintain varied outlooks on the stock. Wells Fargo downgraded the stock to Underweight on August 10, 2026, with an $18.00 target. Truist Securities maintained a Hold rating and raised its target from $19.00 to $24.00 on August 13, 2026. Barclays maintained an Equal-Weight rating and raised its target from $20.00 to $27.00 on August 21, 2026. Freedom Capital Markets downgraded the stock to Hold with a $27.00 target on September 8, 2026. Evercore ISI Group maintained an In-Line rating and lowered its target from $40.00 to $35.00 on September 29, 2026. The stock holds a consensus Hold rating and a mean price target of $30.44 across 18 analyst opinions.

About Doximity

Doximity, Inc. operates a digital platform for medical professionals in the United States, providing networking, telehealth, and workflow tools tailored for clinicians.

Bottom Line

Investors will watch the upcoming earnings report on November 5, 2026, for further updates on the company's financial health. Insider transactions remain subject to pre-arranged trading plans filed with regulators.